Shiv Sarin to Drug Therapy, Combination
This is a "connection" page, showing publications Shiv Sarin has written about Drug Therapy, Combination.
Connection Strength
0.161
-
A randomized open label trial of tenofovir monotherapy versus tenofovir plus telbivudine in spontaneous reactivation of hepatitis B. Saudi J Gastroenterol. 2019 Sep-Oct; 25(5):319-326.
Score: 0.074
-
Generic sofosbuvir-based direct-acting antivirals in hepatitis C virus-infected patients with chronic kidney disease. Liver Int. 2018 12; 38(12):2137-2148.
Score: 0.067
-
Management protocols for hepatitis B. Indian J Gastroenterol. 2001 Mar; 20 Suppl 1:C52-4.
Score: 0.020